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1. Introduction 
Biomineralization is the process by which mineral crystals are deposited in an organized 
fashion in the matrix (either cellular or extracellular) of living organisms (Boskey, 1998). In 
simple terms, it can be described as the widespread and fascinating process by which living 
organisms produce minerals (Sigel et al., 2008; Stephen and Lowenstam, 1989). In this 
process, a living organism provides a chemical and physical environment that controls the 
nucleation and growth of a unique mineral phase. Often these materials exhibit hierarchical 
structural order, leading to superior physical properties not found in either their inorganic 
counterparts or in synthetic materials. The incorporation of inorganic compounds, such as 
salts, into biological structures often lends the structures hardness or rigidity. Almost 70 
different mineral types are known to be formed by organisms from all the kingdoms. 
Examples include silicates in algae, carbonates in diatoms and invertebrates, and calcium 
phosphates and carbonates in vertebrates. These minerals adopt complex and genetically 
determined shapes, are often aligned to form arrays, and fulfill many different functions. 
These include the mechanical functions of exo- and endo-skeletons, temporary storage of 
minerals, stiffening of soft tissues, and much more. In vertebrates, especially mammals, bone 
and tooth are major biominerals. 
Bones are living, growing tissue. During our lifetime, bone is constantly being renewed; there 
is localized removal of old bone (resorption) and replacement with newly formed bone. This 
coupled process is called bone remodeling. Biomineralization of bone—essential for its 
hardness and strength—involves a well orchestrated process in which crystals of calcium 
phosphate are deposited on the matrix produced by bone-forming cells (Weiner et al., 1999). 
Because bone formation consists of components including cells, matrix, and inorganics, the 
process is investigated by different research fields including cellular and molecular biology, 
organic and inorganic chemistry, crystallography, and material science (Figure 1). 
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 Fig. 1. Components of bone biomineralization. Bone forming cells (osteoblasts) produce extracellular matrix on which minerals are deposited. 
 
Special attention has been paid to apatite materials because of their physicochemical 
properties, thermal stability, and biocompatibility that make them suitable for biomedical 
applications (Narasaraju et al., 1996). The usage of apatite-related biomaterials mainly 
focused on bone substitution or bone cements in the early years of study (Ono et al., 1990), 
however, the target has expanded to bone regeneration and drug delivery systems (Komleva 
et al., 2002). Therefore, material characteristics, including cellular and tissue compatibility, 
biodegradability, and drug loading capacity, should be improved. Moreover, it is desirable 
to create materials that can actively instruct cell fate in the area surrounding the material to 
enhance bone regeneration. To obtain such materials, research has focused on developing 
ideas based on biological mineralization systems. In this chapter, the latest research trends 
related to biomimetic apatite materials as well as biomimetic fabrication of apatite related 
biomaterials are introduced. 
 
2. Basics of biominralization of bones 
To obtain biomimetic apatite materials or to develop biomimetic methods of fabricating 
them, it is crucial to understand the natural biomineralization process of bones. The 
biomineralization process of bone can be simply divided into three parts at the microscopic 
level as follows, though the process differs depending on the ossification manner (e.g. 
osteochondral, intramembranous), stage (e.g. development, fracture healing), region, or age. 
1) Osteogenic differentiation of mesenchymal stem cells (MSCs). 
2) Organization of matrix proteins secreted from osteoblasts. 
3) Nucleation and crystal growth of apatite minerals on matrix. 
 
2.1. Osteogenic differentiation of mesenchymal stem cells (MSCs): 
As a result of the capacity for self-renewal and differentiation, bone marrow derived stromal 
cells were first considered as stem cells and named mesenchymal stem cells (MSCs). 
However, in the bone marrow, stromal cells are a rare and heterogeneous population of cells 
that contain a mixture of progenitors at different stages of commitment to the mesodermal 
lineage and only a very small number of multipotential self-renewing stem cells (Caplan, 
1991). It is now accepted that most bone marrow derived progenitor stromal cells can be 
considered, after in vitro proliferation, to be MSCs (Horwitz et al., 2005). Consequently, MSCs 
are typically defined as adherent, fibroblastoid-like cells that differentiate to osteoblasts, 
adipocytes, and chondrocytes in vitro. Despite their functional heterogeneity, in vitro MSCs 
are defined as nonhematopoietic cells (CD45-, CD14-, CD34-) but express other molecules, 
the combination of which is largely used for their description: CD73+, CD44+, CD105+, 
CD90+ and CD146+. 
 
Key factors In vivo and in vitro effects 
TGFbeta Can induce osteoblast differentiation at the early stage of immature 
cells but can also inhibit osteogenesis in committed cells. 
BMP2 Osteochondrogenic factor; might initiate bone formation and bone 
healing and can induce expression of other BMPs 
BMP4 Osteochondrogenic factor in vivo and in vitro 
BMP7 Osteogenic factor in vivo and in vitro; active on more mature 
osteoblasts 
Noggin Suppresses osteoblastic differentiation 
FGFb Mutations induce chondrodysplasia and craniosynostosis; can 
stimulate Sox9; might be a negative regulator of postnatal bone 
growth and remodeling 
IGF-I, II Stimulates growth plate formation, endochondrate ossification and 
bone formation by osteoblasts 
VEGF Most potent angiogenic and vasculogenic factor; crucial at the onset 
of bone formation 
PlGF Induces proliferation and osteogenic differentiation of MSCs; crucial 
for vascularization 
Wnts Depending on Wnt type, crucial for osteoprogenitor proliferation; 
can also inhibit final osteoblast maturation 
Ihh Pivotal role for growth plate and endochondral formation; can inhibit 
osteoblast differentiation; might induce PTHrP expression 
PTHrP Pivotal role for growth plate and endochondral formation; can induce 
or inhibit osteogenesis 
OPG Strongly inhibits bone resorption and has a pivotal role in bone 
Remodeling. 
RANKL Strongly stimulates bone resorption and has a pivotal role in bone 
remodeling 
MAPKs Crucial for regulation of intracellular signaling induced by osteogenic 
factors (still controversial) 
Runx2 Master regulator of early osteogenesis; runx2_/_ mice died, with no 
bone formation 
Osterix Master regulator of late osteogenesis, inhibiting chondrogenesis 
Dlx5 Induces osteoblast maturation but inhibits osteocyte formation 
Msx2 Induces proliferation of immature cells; responses depend on Dlx5 
quantity 
NF-kB Inhibits the differentiation of MSCs and committed osteoblastic cells 
Table 1.Molecules involved in bone formation (Modified from Deschaseaux et al., 2009) 
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As shown in Table 1 a range of cytokines modulate osteoblast differentiation, including bone 
matrix-derived transforming growth factor beta (TGF-), bone morphogenetic protein2 
(BMP-2), BMP-4, and BMP-7, and their inhibitors noggin, chordin, gremlin, etc. Transcription 
factors that regulate the osteoblast include a range of homeodomain proteins: the activator 
protein (AP) family members Jun, Fos, and Fra, Smads, CCAAT/enhancer binding protein 
(C/EBP) and C/EBP δ , lymphoid-enhancing factor (a Wnt effector), activating 
transcription factor 4, Runt-related transcription factor 2 (Runx2), and osterix, the last 3 of 
which are considered master genes for osteoblast differentiation. Runx2 is critical for 
osteoblast differentiation and two homeobox protein Dlx5 and Msx2 regulate Runx2 activity 
via a protein-protein binding interactions (Shirakabe et al., 2001). Thus, owing to the specific 
signal activation including transcriptional dynamics, MSCs differentiate into osteoblasts 
(Figure 2). 
 
2.2. Secretion of matrix proteins by osteoblasts 
Recruited and differentiated osteoblasts play a key role in biomineralization by secreting 
matrix proteins including collagen and non-collagenous proteins (NCP). Most tissues have 
been shown to contain a mixture of different collagen types. Bone, however, appears to 
contain almost exclusively type I collagen, with some type V (Broek et al., 1985). Type I 
collagen is the most common of the collagens in vertebrates. It comprises up to 90% of the 
skeletons of mammals and is also widespread all over the body, giving various tissues their 
mechanical strength and providing the major biomechanical scaffold for cell attachment and 
anchorage of macromolecules. Though type I collagen has multisectorial tasks, in bones type 
I collagen is mineralized with apatite crystals and gives mechanical strength and bone 
flexibility, and, moreover, it facilitates bone mineralization (Mirja et al., 2001). 
Other important matrix proteins secreted by osteoblasts are NCP, including osteopontin 
(OP), bone sialoprotein (BSP), osteonectin (ON), and osteocalcin (OC). OP has important 
roles in immune functions, acts as an important anti-apoptotic factor in many circumstances 
(Denhardt et al., 2001), and also functions as an adhesion protein involved in cell attachment 
and wound healing (Wang et al., 2008). It plays a pivotal role in anchoring osteoclasts or 
hematopoietic stem cells to the mineral matrix of bones and thereby regulates their fate 
(Nilsson et al., 2005). OP contains a string of polyaspartic acid residues as well as an RGDS 
sequence near the middle of the primary sequence, where it has higher affinity with 
hydroxyapatite (HAp). BSP is a phosphoprotein that contains large stretches of polyglutamic 
acids as well as the RGD integrin-binding sequence at its carboxy terminus (Ganss et al., 
1999). Its expression is generally limited to the later stages of osteoblast differentiation and 
early stages of mineralization. BSP also has a high affinity for calcium ions. ON is an acidic, 
secreted extracellular matrix glycoprotein. ON binds strongly to HAp (Romberg et al., 1985) 
even in the presence of 4M guanidinium hydrochloride. Alkaline phosphatase (ALP) 
secreted by osteoblasts is responsible for increasing local inorganic phosphate concentration 
during apatite formation (Hoffmann et al., 2008). Notably, these NCP can adhere to collagen 
fibers via strong physical adsorption or covalent bindings. Therefore, NCP coupling with 
type I collagen is considered to be an important template for mineralization. Indeed, 
numerous studies indicate that HAp orientation correlates with collagen orientation (Iijima 
et al., 1997b). OC is abundant in the synthesized osteogenic matrix, binds to phospholipid 
vesicles in the presence of Ca2+, and also binds HAp. It has been stipulated that OC may 
function as a negative regulator of bone formation, although its exact role is unknown. 
 Fig. 2. Schematic illustration of differentiation of mesenchymal stem cells. 
 
2.3. Nucleation and crystal growth of apatite minerals on matrix 
It now appears clear that type I collagen alone is biologically insufficient to induce 
mineralization. It is thought that in bone, an interaction between anionic proteins and type I 
collagen fibrils may provide a stereochemical orientation of negatively charged groups that 
acts as a HAp nucleator. In vitro studies of organic matrix on biological crystal formation 
have proved a powerful complement to ultrastructural approaches in the ongoing attempt to 
determine the mechanism of calcification in bone and epiphyseal cartilage. However, much 
confusion has been generated by the fact that anionic matrix molecules often act as 
calcification inhibitors in these systems by complexing calcium ions and, in some cases, 
inhibiting crystal growth by adsorption onto specific crystal faces. For example, an 
aspartate-rich protein adsorbs to specific faces of growing apatite crystal, inhibiting the 
development of these faces and hence altering the crystal morphology (Addadi and Weiner, 
1985). An important conceptual breakthrough has been the realization that macromolecules 
with a high density of negatively charged groups may act as crystal nucleators if 
immobilized onto solid-phase surfaces (Linde et al., 1989). 
 Similarly, amphipathic lipid monolayers or bilayers may promote calcification in an adjacent 
solution phase. Matrix vesicles secreted from osteoblasts are also considered to be a major 
site of biomineral nucleation  (Figure 3).  There are electron microscopy reports from 
researchers claiming that the mineralization process may involve the mobilization and 
translocation of insoluble mitochondrial calcium phosphate to the plasma membrane. 
According to this scheme, ions are ‘packaged’ and pinched off within trilaminar 
membrane-bound vesicles that are enriched and complexed with acidic phospholipid and 
contain NCP/proteolipid (Glinder et al., 1989). The phosphate-containing ALP within these 
new extracellular matrix vesicles is a species that is electrophoretically distinct from the form 
of the enzyme that is restricted to intracellular sites (Arsenis et al., 1976). Then, mineral 
formation penetrates the vesicle membrane and, in the presence of Ca+2, PO4-3, and 
pyrophosphate, serves as the nuclei for formation of needle-shaped apatite. Finally, 
proliferation of the apatite spreads outwards into the matrix, rupturing the matrix vesicle 
(Anderson et al., 1969). 
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 Fig. 3. Matrix vesicle secreted by osteoblasts (Left). Mineralized matrix vesicles (Right). 
 
3. Bone minerals 
The crystals of bone apatite are extremely small (crystallites). By x-ray diffraction, crystal size 
has been found to range in its long dimension (c-axis) from 10–25 nm (Boskey et al., 1985; 
Grynpas et al., 1986). By electron microscopy, bone crystal length has been found to vary 
from 30–70 nm (Landis et al., 1978). Therefore, bone mineral has a huge surface area of 
between 85 and 170 m2/g (Ortner, 2003).  
 
There are essentially five solid phases of calcium phosphate that have been linked to 
biological mineralization (Table 2). Of these, HAp (Ca10(PO4)6(OH)2) (Figure 4) is universally 
recognized as the final solid mineral phase of bone. All others have been implicated as minor 
or precursor phases; they are acid stable and will convert to the thermodynamically stable 
and insoluble HAp at a high pH.  HAp alone is stable at neutral or basic pH. Tricalcium 
phosphate (Ca3(PO4)2, TCP) requires the presence of Mg for its formation at room 
temperature. Both dicalcium phosphate dihydrate (CaHPO4•2H2O, DCPD) and octacalcium 
phosphate (Ca8H2(PO4)6•5H2O, OCP) have acid phosphate groups (HPO4) and a structural 
plane on which HAp can be grown epitaxially (Neuman and Neuman, 1958). Studies suggest 
that platelets are the dominant morphology of bone apatite (Traub et al., 1989). The 
formation of plate-like crystals in the mineralized collagen fibrils is still not fully understood. 
One possible explanation for this mineral morphology in bone is that crystal growth occurs 
via an OCP intermediate (Brown et al., 1962; Weiner and Traub, 1992). OCP has nearly the 
same crystal structure as HAp but contains an extra hydrated layer that may be responsible 
for the observed plate-shaped crystals in natural bone. Amorphous calcium phosphate (ACP) 
was also found to spontaneously precipitate to apatite at physiological values in vitro (Eanes 
et al., 1965). However, Grynpas et al. could not detect the presence of ACP in young bone 
(Grynpas et al., 1984). Improved methods of imaging and structure determination have since 
led to the identification of stable and transient forms of amorphous precursors in 
biomineralization of calcium carbonate in sea urchin spines and spicules (Addadi et al., 2003; 
Politi et al., 2004;  Politi et al., 2006). As a result, the role of amorphous phases in 
mineralization of HAp in biological tissues such as bone continues to be a subject of great 
research interest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Hydroxyapatite crystal 
 
Phosphates (PO4) in the general formula of HAp can be CO3, SO4, VO4, AsO4, or SiO4. A 
variety of metals can take the place of Ca in the formula. In case of natural apatites, the main 
cation is Ca and Mg is secondary. The last group (OH)2 can be F2, Cl2, Br2, or CO3 (Zipkin, 
1973). Chemical analysis has shown that in hard biological tissues, i.e., bone, enamel, and 
dentine, the biological apatites are not pure HAp, but contain a mixture of minor elements, 
including CO3, HPO4, F, Cl, Mg, and Na ions (Yoshikawa and Myoui, 2005). Based on the 
knowledge derived from biological mineralization systems, researchers, especially material 
scientists and chemists, are now seeking biomimetic apatite-related biomaterials. 
 
Name Formula Abbreviation Molar ratio 
Hydroxyapatite Ca10(PO4)6(OH)2 HAp 1.67 
Tricalcium phosphate Ca3(PO4)2 TCP 1.50 
Octacalcium phosphate Ca8H2(PO4).5H2O OCP 1.33 
Dicalcium phosphate 
dihydrate 
CaHPO4・2H2O DCPD 1.00 
Amorphous calcium 
phosphate 
 ACP 1.30-1.50 
Table 2. Solid phases of biological calcium-phosphate 
 
4. In vitro approaches to fabricating biomimetic inorganic materials 
4.1. Biomimetic apatite: Ionically substituted apatite 
Apatite powders can be synthesized via numerous production routes with a range of 
different reactants. Processing techniques include wet chemical methods (precipitation), 
hydrothermal techniques, hydrolysis of other calcium phosphates, and sol-gel methods. 
Since biological minerals, especially the apatite found in bone, are often ionically substituted 
apatite, apatite materials substituted by ions have been synthesized to control the 
www.intechopen.com
Biomimetic fabrication of apatite related biomaterials 295
 Fig. 3. Matrix vesicle secreted by osteoblasts (Left). Mineralized matrix vesicles (Right). 
 
3. Bone minerals 
The crystals of bone apatite are extremely small (crystallites). By x-ray diffraction, crystal size 
has been found to range in its long dimension (c-axis) from 10–25 nm (Boskey et al., 1985; 
Grynpas et al., 1986). By electron microscopy, bone crystal length has been found to vary 
from 30–70 nm (Landis et al., 1978). Therefore, bone mineral has a huge surface area of 
between 85 and 170 m2/g (Ortner, 2003).  
 
There are essentially five solid phases of calcium phosphate that have been linked to 
biological mineralization (Table 2). Of these, HAp (Ca10(PO4)6(OH)2) (Figure 4) is universally 
recognized as the final solid mineral phase of bone. All others have been implicated as minor 
or precursor phases; they are acid stable and will convert to the thermodynamically stable 
and insoluble HAp at a high pH.  HAp alone is stable at neutral or basic pH. Tricalcium 
phosphate (Ca3(PO4)2, TCP) requires the presence of Mg for its formation at room 
temperature. Both dicalcium phosphate dihydrate (CaHPO4•2H2O, DCPD) and octacalcium 
phosphate (Ca8H2(PO4)6•5H2O, OCP) have acid phosphate groups (HPO4) and a structural 
plane on which HAp can be grown epitaxially (Neuman and Neuman, 1958). Studies suggest 
that platelets are the dominant morphology of bone apatite (Traub et al., 1989). The 
formation of plate-like crystals in the mineralized collagen fibrils is still not fully understood. 
One possible explanation for this mineral morphology in bone is that crystal growth occurs 
via an OCP intermediate (Brown et al., 1962; Weiner and Traub, 1992). OCP has nearly the 
same crystal structure as HAp but contains an extra hydrated layer that may be responsible 
for the observed plate-shaped crystals in natural bone. Amorphous calcium phosphate (ACP) 
was also found to spontaneously precipitate to apatite at physiological values in vitro (Eanes 
et al., 1965). However, Grynpas et al. could not detect the presence of ACP in young bone 
(Grynpas et al., 1984). Improved methods of imaging and structure determination have since 
led to the identification of stable and transient forms of amorphous precursors in 
biomineralization of calcium carbonate in sea urchin spines and spicules (Addadi et al., 2003; 
Politi et al., 2004;  Politi et al., 2006). As a result, the role of amorphous phases in 
mineralization of HAp in biological tissues such as bone continues to be a subject of great 
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Fig. 4. Hydroxyapatite crystal 
 
Phosphates (PO4) in the general formula of HAp can be CO3, SO4, VO4, AsO4, or SiO4. A 
variety of metals can take the place of Ca in the formula. In case of natural apatites, the main 
cation is Ca and Mg is secondary. The last group (OH)2 can be F2, Cl2, Br2, or CO3 (Zipkin, 
1973). Chemical analysis has shown that in hard biological tissues, i.e., bone, enamel, and 
dentine, the biological apatites are not pure HAp, but contain a mixture of minor elements, 
including CO3, HPO4, F, Cl, Mg, and Na ions (Yoshikawa and Myoui, 2005). Based on the 
knowledge derived from biological mineralization systems, researchers, especially material 
scientists and chemists, are now seeking biomimetic apatite-related biomaterials. 
 
Name Formula Abbreviation Molar ratio 
Hydroxyapatite Ca10(PO4)6(OH)2 HAp 1.67 
Tricalcium phosphate Ca3(PO4)2 TCP 1.50 
Octacalcium phosphate Ca8H2(PO4).5H2O OCP 1.33 
Dicalcium phosphate 
dihydrate 
CaHPO4・2H2O DCPD 1.00 
Amorphous calcium 
phosphate 
 ACP 1.30-1.50 
Table 2. Solid phases of biological calcium-phosphate 
 
4. In vitro approaches to fabricating biomimetic inorganic materials 
4.1. Biomimetic apatite: Ionically substituted apatite 
Apatite powders can be synthesized via numerous production routes with a range of 
different reactants. Processing techniques include wet chemical methods (precipitation), 
hydrothermal techniques, hydrolysis of other calcium phosphates, and sol-gel methods. 
Since biological minerals, especially the apatite found in bone, are often ionically substituted 
apatite, apatite materials substituted by ions have been synthesized to control the 
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characteristics of apatite materials. When HAp is synthesized in the presence of Mg, Fe, CO3, 
or F, these ions are readily and partly substituted at certain positions (e.g., Mg and Fe at the 
Ca site, CO3 at the PO4 site, and CO3 and F at the OH site) in HAp crystals. The ionically 
substituted HAp exhibits different characteristics than normal HAp. For example, the 
solubility of apatite containing Mg, Fe, or CO3 substitution increases with the increase in the 
concentration of the substitute ion (Gibson and Bonfield, 2002; Suchanek et al., 2004; 
Morrissey et al., 2005), whereas the stability of crystals increases and solubility decreases in 
apatite with F substitution (Okazaki et al., 1998; Okazaki et al., 1981). In addition to those, Sr- 
or Zn-substituted HAp crystals were synthesized by researchers. Sr-containing HAp 
enhanced the proliferation and differentiation of osteoblasts (e.g., MG63) (Capuccini et al., 
2008). It also facilitated the nucleation of HAp, therefore, Sr-containing HAp is might be 
usable as a template for growing new bone (Pan et al., 2009). Zn-containing HAp increases 
the specific surface area (Tonegawa et al., 2007) and decreases the thermal stability of HAp 
(Li et al., 2008). Thus, ionic substitution, which occurs in natural apatite, is effective for 
controlling both material and biological characteristics of apatite. 
 
4.2. Apatite formation via biomimetic mineralization 
Researchers are also developing new synthetic, biomimetic systems to obtain apatite 
materials with biomimetic crystal morphology and size. Iijima et al. focused on the OCP 
crystal growth methods similar to the biological system. A collagen disk prepared from 
bovine Achilles tendon, which shows specific uniaxial alignment, was used as the template 
for OCP crystal formation. Consequently, the researchers were able to reproduce a 
ribbon-like OCP crystal formation morphologically close to the biological apatite precursors 
(Iijima et al., 1997b) (Figure 5a). 
 
Fig. 5. a) OCP crystals (Iijima et al., 2002) Copyright 2002 IADR, b) Apatite formation on 
metal substrate. Copyright 2008 Elsevier. 
 
Since simulated body fluid (SBF) containing inorganic ions similar to those in human plasma 
has been developed, SBF is considered to be a robust tool for reproducing biological apatite 
formation in vitro. Coating a bone-like apatite layer on substrate is expected to be a useful 
technique for inducing bioactivity on the substrate. The bone-like apatite layer can be formed 
on the surface of substrates in SBF solution when several specific functional groups are 
introduced to the substrates. Coating bone-like apatite layers through this biomimetic 
process has received much attention in the fabrication of novel bioactive composites 
(Kamitakahara et al., 2007). Often, the biomimetic apatite coating is developed on the surface 
of titanium and its alloys. Gu et al. developed a method for biomimetic deposition of apatite 
coating on surface-modified NiTi alloy. They prepared a TiO2 coating on NiTi alloy by heat 
treatment in air. The heat-treated NiTi alloy was then immersed in SBF for the biomimetic 
deposition of the apatite layer onto the surface of the TiO2 coating. XPS and Raman results 
showed that this apatite layer was a carbonated and non-stoichiometric apatite with a Ca/P 
ratio of 1.53, which is similar to human bone (Gu et al., 2005). Ohtsuki et al. reported in vitro 
formation of small crystallities of carbonate-containing apatite on the surface of 
Ceravital-type glass ceramics soaked in SBF (Ohtsuki et al., 1991). 
Moreover, there are reports about biomimetic methods of apatite formation using simpler 
solutions than SBF. For example, Bigi et al. reported a new fast method for the development 
of nanocrystalline HAp coatings on Ti6Al4V substrates using a slightly supersaturated Ca/P 
solution with an ionic composition simpler than that of SBF (Bigi et al., 2005). Shi et al. also 
followed the same biomimetic approach to synthesize an apatite layer on the surface of 
NaOH-modified titanium coatings in supersaturated solutions containing Ca2+ and HPO42− 
ions. They observed that, depending on the ion composition and concentration of the 
solution, apatite layers were formed with preferred orientation and a composition similar to 
that found in bone (Shi et al., 2001) (Figure 5b). 
 
5. In vitro approaches to fabricate biomimetic organic/inorganic  
composite materials 
5.1. HAp containing organics 
Improvement of physico-chemical characteristics (e.g., crystallinity, solubility, adsorptive 
properties, etc.) of apatite is important for using apatite-based materials for biomedical 
applications such as bone regeneration. Since acidic molecules have a well documented 
affinity to HAp, researchers synthesized HAp in the presence of organics, including acidic 
molecules and sugars. Previous reports indicated that HAp synthesized with acidic amino 
acids (e.g., aspartic acid, glutamic acid) has decreased crystallinity and increased solubility 
(Kevin, et al., 2007; Matsumoto et al., 2002). FTIR analysis indicated that these HAp crystals 
contained acidic amino acids and showed selective loading capacity of positively charged 
molecules (Uddin et al., 2009) and enhanced osteogenic differentiation of cells (Boanini et al, 
2006). Stupp et al. synthesized HAp using macromolecules such as poly(l-lysine) and 
poly(l-glutamic acid). Poly(l-lysine) generated large single crystals that were flat and thin, 
whereas poly(l-glutamic acid) generated nanoscale crystallites (Stupp et al., 1997). Stupp et al. 
also demonstrated biomimetic mineralization of bone apatite using self-assembling 
molecules known as peptide amphiphiles (Hartgerink et al., 2001). Since the peptide design is 
flexible, this approach would be robust for obtaining HAp crystals with desired structure 
and size. 
 
5.2. Biomimetic mineralization in organic gel to fabricate organic/inorganic  
composite material 
Basically, the methods originate from biochemical studies investigating the effect of matrix 
proteins on biomineralization. Silverman and Boskey developed a gel diffusion precipitation 
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2008). It also facilitated the nucleation of HAp, therefore, Sr-containing HAp is might be 
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molecules and sugars. Previous reports indicated that HAp synthesized with acidic amino 
acids (e.g., aspartic acid, glutamic acid) has decreased crystallinity and increased solubility 
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molecules known as peptide amphiphiles (Hartgerink et al., 2001). Since the peptide design is 
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5.2. Biomimetic mineralization in organic gel to fabricate organic/inorganic  
composite material 
Basically, the methods originate from biochemical studies investigating the effect of matrix 
proteins on biomineralization. Silverman and Boskey developed a gel diffusion precipitation 
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technique for growing large HAp crystals in collagen gel. This group has shown the inter alia 
promotion of HAp formation and growth by acidic phospholipids, biglycan, and BSP 
(Silverman and Boskey, 2004). On the other hand, inhibition of mineralization was observed 
for OP, dentin sialoprotein, aggrecan, and dentin matrix protein-1 (Tartaix et al., 2004). 
Hunter and Goldberg used a variation of the double diffusion gel method (using double 
diffusion of ions from opposite directions into a gel that contains the matrix molecule of 
interest) to explore apatite nucleation and inhibition by a number of matrix proteins (Hunter 
and  Goldberg, 1993). Their system uses an agarose gel separated from calcium and 
phosphate reservoirs by diffusion membranes. SDS-polyacrylamide electrophoretic gel was 
also used as gel diffusion precipitation system. Calcium and phosphate ions were diffused 
naturally or propelled by electric potential. Calcium phosphate was precipitated in the gel. 
The precipitation was affected by proteins in the gel that had been separated by 
electrophoresis. 
From a different stand-point, gels containing precipitated minerals developed in these 
methods are considered to be organic/inorganic composite gel material. Yoh et al. performed 
in vitro fabrication of fibrin/apatite composite material by using gel diffusion systems at 
various pH conditions. The minerals generated in fibrin gel varied with the pH conditions: 
DCPD in the noncontrolled pH solution, a DCPD and OCP mixture at pH 7.4, and an OCP 
and HAp mixture at pH 9.0. The composition of minerals in the gel can be regulated by their 
reaction period or diffusion rate (Yoh et al., 2008) (Figure 6). Watanabe et al. demonstrated 
anisotropic HAp formation in an agarose gel using an electrophoretic approach and an 
alternate soaking process to obtain the composite materials for bone regeneration (Watanabe 
et al., 2007). 
 
 Fig. 6.  Biomimetic mineralization of apatite in fibrin gel.  Copyright 2008 Wiley. 
 
5.3. Cell based fabrication of organic/inorganic composite gel 
Synthesis of organic/inorganic composite materials generated by inorganic nucleation in a 
polymerized matrix is a unique system for obtaining biomimetic materials. Cells might also 
be great contributors to the synthesis of organic/inorganic composite material, because 
secreted proteins, especially those derived from osteogenic differentiated cells, supply 
regions where mineral crystals nucleate and grow. Our group demonstrated that culturing 
MSCs in three-dimensional (3D) gel matrix enhanced the precipitation of cell-derived matrix 
and minerals. The matrix and mineral content in the material can be regulated by cell culture 
conditions including cell number and period. Moreover, 3D cell patterning in the gel has 
been found to be effective in controlling the matrix and mineral position and distribution in 
the gel. Thus, this type of cell-based fabrication technique would be a new approach to 
fabricating more biomimetic materials (Figure 7). 
 
6. Conclusion 
Biological tissue shows amazing characteristics and has functions that cannot be easily 
reproduced by artificial synthesis. For example, bone tissue shows fracture toughness though 
it is soft in nature. Therefore, learning from biological systems gives us tremendous 
opportunities to fabricate materials that we have not yet been able to produce. The ionically 
substituted HAp materials or organic-containing HAp materials introduced in this chapter 
are good candidates for drug delivery carriers for bone regeneration or bone-related diseases. 
Organic/inorganic composite gel materials fabricated by self-precipitation or by a cell-based 
method would be neo-bone tissue that could shorten the bone regeneration period. Thus, 
apatite related biomaterials inspired by nature have potential for numerical biomedical 
applications. 
 
 Fig. 7.  Schematic illustration of biomimetic mineralization in fibrin gel culturing with MSCs. 
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